You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COVID-19, SARS-CoV-2, ddPCR, cancer, serology

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, COVID Trial in Lyon (Nasopharyngeal and throat/oropharyngeal swabs analyses by RT-PCR and ddPCR)

Active, not recruiting
  • Cancer
  • COVID
  • Nasopharyngeal and throat/oropharyngeal swabs analyses by RT-PCR and ddPCR
  • Lyon, France
    Centre Leon Berard
Oct 14, 2021

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2

Recruiting
  • Covid19
  • Serologic immunoassays to SARS-CoV-2 antibodies
  • Detroit, Michigan
    Henry Ford Health System
Dec 13, 2022

Exploratory Study: COVID-19 and Pregnancy

Recruiting
  • Pregnant Women
  • Covid19
  • SARS-CoV-2 serology
  • São Paulo, Brazil
    Rossana P Fracisco
Jun 7, 2022

COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

Not yet recruiting
  • COVID-19 Vaccine
  • COVID-19
  • 50 μg Baiya SARS-CoV-2 Vax 2
  • Placebo
  • Bangkok, Thailand
    Queen Saovabha Memorial Institute
May 23, 2023

Covid19 Trial in Charleroi (Serology to determine SARS-CoV-2 infection)

Completed
  • Covid19
  • Serology to determine SARS-CoV-2 infection
  • Charleroi, Hainaut, Belgium
    Grand Hôpital de Charleroi
May 31, 2022

COVID-19, Post-COVID-19 Syndrome, Influenza Trial in Kunming (Autonomous Treatment System for Covid-19, Post-Acute Sequelae of

Enrolling by invitation
  • COVID-19
  • +2 more
  • Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning
  • Kunming, Yunnan, China
    Sheng'Ai Traditional Medicine Hospital
Sep 22, 2023

COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

Not yet recruiting
  • COVID-19
  • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
  • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
  • (no location specified)
Aug 4, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

SARS-CoV-2 Vaccination on Cancer Patients Infected With

Recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine
  • no intervention
  • Beijing, Beijing, China
    Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023

SARS-CoV-2 in Stools Compared to Respiratory Viral Strains.

Not yet recruiting
  • SARS-CoV-2 Infection
  • Biological assays
  • Vandoeuvre Les Nancy, France
    Schvoerer
Oct 1, 2022

COVID-19 Transmission and Morbidity in Malawi

Recruiting
  • SARS CoV 2 Infection
  • SARS CoV 2 Vaccination
    • Boston, Massachusetts
    • +1 more
    Aug 6, 2023

    COVID-19 Infection Trial in ¨Paris (serology test, nasopharyngeal swab, rectal swab)

    Completed
    • COVID-19 Infection
    • serology test
    • +3 more
    • ¨Paris, France
      Hôpital necker Enfants-Malades
    Feb 1, 2023

    Pregnancy Trial in Paris (identify SARS-CoV-2 infection by serology, collection of biological samples)

    Completed
    • Pregnancy
    • identify SARS-CoV-2 infection by serology
    • collection of biological samples
    • Paris, France
      Tsastaris Vassillis
    Jun 20, 2022

    SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

    Recruiting
    • SARS-CoV2 Infection
    • General SARS-CoV-2 Communication
    • Rural-Targeted SARS-CoV-2 Communication
    • Flint, Michigan
      Flint Journal Building
    Oct 10, 2023

    SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • +2 more
    • eBAM Cov Testing
    • Marseille, France
    • +1 more
    Oct 23, 2023

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +2 more
    • SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 13, 2022

    A Study of the Effectiveness of Moderna COVID-19 Vaccine

    Recruiting
    • SARS-CoV-2
    • COVID-19
    • mRNA-1273
    • Pasadena, California
      Kaiser Permanente Southern California
    Jul 5, 2023

    Serology to COVID-19 for Recording Exposures and Evaluating

    Terminated
    • Covid19
    • +2 more
    • SARS-CoV-2
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Dec 7, 2021

    LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

    Not yet recruiting
    • SARS-CoV-2
    • +4 more
    • LumiraDx SARS-CoV-2 Ag Ultra
    • LumiraDx SARS-CoV-2 & Flu A/B
    • DeLand, Florida
      Hillcrest Medical Research
    Feb 6, 2023

    Sars-Covid-19 Vaccines in Haematological Patients: Prospective

    Completed
    • Hematologic Diseases
    • IgG antibodies to Sars-Cov-2
    • QuantiFERON SARS-CoV-2 test
    • Monza, Lombardia, Italy
      San Gerardo Hospital
    Jan 23, 2023

    Covid19, SARS-COV-2 Infection Trial (DWJ1248, Placebo)

    Terminated
    • Covid19
    • SARS-COV-2 Infection
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Dec 4, 2022

    COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

    Recruiting
    • COVID-19
    • SARS-CoV-2 DNA Vaccine (ICCOV)
    • Wong Chuk Hang, Hong Kong
      Gleneagles Hospital Hong Kong
    Jun 16, 2023

    COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

    Completed
    • COVID-19
    • SARS-CoV-2 Infection
    • Quantitative analysis of SARS-CoV-2 antibodies
    • Cellular immunity
    • Prague, Czechia
      Institute of Health Information and Statistics of the Czech Repu
    Nov 25, 2022

    Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus

    Not yet recruiting
    • COVID-19
    • Diabete Mellitus
    • Measure of physiologic parameters
    • San Antonio, Texas
      Texas Diabetes Institute - University Health System
    May 17, 2023

    SARS-CoV-2 Infection Trial in Shinagawa-ku (S-217622, Placebo)

    Recruiting
    • SARS-CoV-2 Infection
    • Shinagawa-ku, Higashioi, Japan
      Tokyo Shinagawa Hospital Social Medical Corporation Association
    Jun 13, 2023